Neuromuscular Blocking Agents Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Neuromuscular Blocking Agents. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Neuromuscular Blocking Agents Indian Medical PG Question 1: A person was given a muscle relaxant that competitively blocks nicotinic receptors. Which of the following drugs is used for reversal of muscle relaxation after surgery?
- A. Carbachol
- B. Succinylcholine
- C. Physostigmine
- D. Neostigmine (Correct Answer)
Neuromuscular Blocking Agents Explanation: ***Neostigmine***
- **Neostigmine** is an **acetylcholinesterase inhibitor** that increases the amount of acetylcholine at the neuromuscular junction, thereby overcoming the competitive block at nicotinic receptors [1], [4].
- This increase in acetylcholine effectively reverses the paralysis caused by **nondepolarizing muscle relaxants**, making it useful for post-surgical recovery [2].
*Carbachol*
- **Carbachol** is a **direct-acting cholinergic agonist** that stimulates both muscarinic and nicotinic receptors and is not typically used for reversing competitive neuromuscular blockade.
- Its primary use is for glaucoma and to stimulate the bladder or bowels, not to counteract muscle relaxants.
*Succinylcholine*
- **Succinylcholine** is a **depolarizing muscle relaxant** and would prolong, rather than reverse, muscle blockade if administered after a competitive blocker [3].
- It works by initially causing depolarization and then preventing further muscle contraction, leading to paralysis.
*Physostigmine*
- **Physostigmine** is an **acetylcholinesterase inhibitor** that crosses the blood-brain barrier, making it more suitable for treating central anticholinergic toxicity rather than peripheral neuromuscular blockade.
- While it inhibits acetylcholinesterase, its central effects and potential for seizures limit its use for reversing surgical muscle relaxation.
Neuromuscular Blocking Agents Indian Medical PG Question 2: Non-depolarizing neuromuscular blocker is characterized by
- A. Non competitive neuromuscular blocker
- B. Reversed by neostigmine (Correct Answer)
- C. Induces fasciculations
- D. Persistent stimulator of nicotinic cholinergic receptors
Neuromuscular Blocking Agents Explanation: ***Reversed by neostigmine***
- **Non-depolarizing neuromuscular blockers** are **competitive antagonists** at the **nicotinic acetylcholine receptors** at the neuromuscular junction.
- **Neostigmine** is an **acetylcholinesterase inhibitor** that increases the concentration of acetylcholine in the synaptic cleft, thereby overcoming the competitive blockade.
*Non competitive neuromuscular blocker*
- Non-depolarizing neuromuscular blockers are, by definition, **competitive antagonists** at the **nicotinic acetylcholine receptors**.
- A non-competitive blocker would bind to a different site on the receptor or an allosteric site to produce its effect.
*Induces fasciculations*
- **Fasciculations** (visible muscle twitching) are characteristic of **depolarizing neuromuscular blockers** like **succinylcholine**, as they initially activate the receptors before causing prolonged depolarization and paralysis.
- Non-depolarizing blockers do not typically cause fasciculations because they prevent acetylcholine from binding and activating the receptors.
*Persistent stimulator of nicotinic cholinergic receptors*
- This describes the mechanism of action of **depolarizing neuromuscular blockers** like **succinylcholine**, which persistently activate the receptor, leading to initial fasciculations followed by sustained depolarization and paralysis.
- **Non-depolarizing blockers** act as **antagonists**, preventing activation of the receptors.
Neuromuscular Blocking Agents Indian Medical PG Question 3: The anaesthesia of choice in renal disease is which one of the following:
- A. Atracurium
- B. Cisatracurium (Correct Answer)
- C. Vecuronium
- D. Rocuronium
Neuromuscular Blocking Agents Explanation: ***Cisatracurium***
- **Cisatracurium** is preferred in renal disease because it undergoes **Hofmann elimination**, a chemical breakdown independent of renal or hepatic function.
- Its metabolism generates **laudanosine**, a metabolite that can accumulate in renal failure but has minimal clinical significance at typical doses.
*Atracurium*
- **Atracurium** also undergoes **Hofmann elimination** and ester hydrolysis, making it suitable for renal patients, but it produces more **laudanosine** than cisatracurium.
- Higher levels of **laudanosine** can potentially cause central nervous system excitation (seizures) with prolonged use or in very high doses, although this is rare in clinical practice.
*Vecuronium*
- **Vecuronium** is primarily eliminated by the **liver** and, to a lesser extent, by the kidneys, so its duration of action can be prolonged in renal failure.
- Its active metabolites, particularly **3-desacetylvecuronium**, accumulate significantly in renal insufficiency, leading to prolonged neuromuscular blockade.
*Rocuronium*
- **Rocuronium** is mainly eliminated by the **liver** (approximately 70-80%), with a smaller portion excreted renally.
- In patients with renal failure, its duration of action can be significantly prolonged due to reduced renal clearance and potential alterations in hepatic elimination.
Neuromuscular Blocking Agents Indian Medical PG Question 4: In pseudocholinesterase deficiency, which drug should be used cautiously?
- A. Succinylcholine (Correct Answer)
- B. Barbiturates
- C. Gallamine
- D. Halothane
Neuromuscular Blocking Agents Explanation: ***Succinylcholine***
- **Succinylcholine** is primarily metabolized by **pseudocholinesterase** (also known as butyrylcholinesterase).
- In individuals with **pseudocholinesterase deficiency**, the metabolism of succinylcholine is significantly delayed, leading to **prolonged neuromuscular blockade** and extended paralysis.
*Barbiturates*
- **Barbiturates** are mainly metabolized by the **hepatic cytochrome P450 system** and do not depend on pseudocholinesterase for their breakdown.
- Their metabolism would not be significantly affected by pseudocholinesterase deficiency.
*Halothane (an inhalational anesthetic)*
- **Halothane** is primarily metabolized by the **hepatic cytochrome P450 system** and excreted via the lungs.
- Its metabolism is unrelated to **pseudocholinesterase activity**.
*Gallamine (a neuromuscular blocker)*
- **Gallamine** is a **nondepolarizing neuromuscular blocker** that is primarily eliminated by **renal excretion** as an unchanged drug.
- Its metabolism and elimination are independent of **pseudocholinesterase**.
Neuromuscular Blocking Agents Indian Medical PG Question 5: The reversal by sugammadex is possible with all the following neuromuscular blocker except-
- A. Vecuronium
- B. Atracurium (Correct Answer)
- C. Pancuronium
- D. Rocuronium
Neuromuscular Blocking Agents Explanation: ***Atracurium***
- **Sugammadex** is a modified gamma-cyclodextrin that specifically encapsulates and inactivates **aminosteroid neuromuscular blocking agents**.
- **Atracurium** is a **benzylisoquinolinium** agent, not an aminosteroid, therefore it cannot be reversed by sugammadex.
*Vecuronium*
- **Vecuronium** is an **aminosteroid neuromuscular blocker**, which means it can be effectively encapsulated and reversed by **sugammadex**.
- Its chemical structure allows for a high affinity binding with sugammadex, leading to rapid reversal of neuromuscular blockade.
*Pancuronium*
- **Pancuronium** is an **aminosteroid neuromuscular blocker** that can be effectively reversed by **sugammadex**.
- Although sugammadex has a lower affinity for pancuronium compared to rocuronium, it can still effectively reverse its blockade.
*Rocuronium*
- **Rocuronium** is an **aminosteroid neuromuscular blocker** with the **highest affinity for sugammadex**, making it the most rapidly and effectively reversed by this agent.
- The strong, non-covalent binding between sugammadex and rocuronium forms a stable complex, preventing rocuronium from interacting with acetylcholine receptors.
Neuromuscular Blocking Agents Indian Medical PG Question 6: Which drug can exhibit Phase II neuromuscular block:
- A. Scoline (Correct Answer)
- B. Cocaine
- C. D-TC
- D. Vencuronium, ether, N2O
Neuromuscular Blocking Agents Explanation: ***Scoline***
- **Scoline** (**succinylcholine**) is a depolarizing neuromuscular blocker that can cause a **Phase II block** with prolonged or high-dose administration.
- In a Phase II block, the neuromuscular junction becomes desensitized to acetylcholine, leading to a block that resembles a **non-depolarizing block**, including fade and post-tetanic potentiation.
*Cocaine*
- **Cocaine** is a local anesthetic and a stimulant; it primarily acts by blocking the reuptake of **norepinephrine**, **dopamine**, and **serotonin** in the central nervous system.
- It does not directly affect the neuromuscular junction to cause a depolarizing or Phase II block.
*Vencuronium, ether, N2O*
- **Vencuronium** is a **non-depolarizing neuromuscular blocker** that produces a competitive block at the neuromuscular junction, which is distinct from a Phase II block.
- **Ether** is an inhaled anesthetic that can cause muscle relaxation but does not typically induce a Phase II neuromuscular block. **N2O** (nitrous oxide) is a weak anesthetic with no significant neuromuscular blocking properties.
*D-TC*
- **d-tubocurarine (d-TC)** is a **non-depolarizing neuromuscular blocker** that competitively antagonizes acetylcholine at the nicotinic receptors.
- Unlike scoline, it does not cause initial depolarization or a subsequent Phase II block.
Neuromuscular Blocking Agents Indian Medical PG Question 7: Mechanism of action of curare-like drugs?
- A. Blocks ACh receptors (Correct Answer)
- B. Agonistic with ACh receptors
- C. Inhibits ACh synthesis
- D. Causes persistent depolarization
Neuromuscular Blocking Agents Explanation: ***Blocks ACh receptors***
- Curare-like drugs are **competitive antagonists** at the **nicotinic acetylcholine receptors (nAChRs)** found at the neuromuscular junction.
- By binding to these receptors, they prevent acetylcholine (ACh) from binding and activating the receptors, thereby **inhibiting muscle contraction**.
*Inhibits ACh synthesis*
- Drugs that inhibit ACh synthesis typically target enzymes like **choline acetyltransferase**.
- This mechanism would reduce the amount of ACh available, but curare acts directly at the *receptor level*.
*Causes persistent depolarization*
- This is the mechanism of action of **depolarizing neuromuscular blockers** like succinylcholine.
- They initially activate the receptor, causing a brief depolarization, followed by a sustained depolarization that renders the muscle unresponsive.
*Agonistic with ACh receptors*
- An agonist binds to and activates a receptor, mimicking the effect of the natural ligand (acetylcholine in this case).
- Curare-like drugs are **antagonists**; they bind to the receptor but do not activate it, instead blocking ACh binding.
Neuromuscular Blocking Agents Indian Medical PG Question 8: Hippus occurs in which poisoning?
- A. Aconite poisoning (Correct Answer)
- B. Opioid poisoning
- C. Neuromuscular blocking agent poisoning
- D. Belladonna poisoning
Neuromuscular Blocking Agents Explanation: ***Aconite poisoning***
- **Hippus**, characterized by alternating **pupillary constriction and dilation**, is a hallmark of aconite poisoning.
- This unusual pupil activity results from the **neurotoxic effects** of aconite on the autonomic nervous system.
*Opioid poisoning*
- Opioid poisoning typically causes characteristic **pinpoint pupils (miosis)** due to parasympathetic overstimulation.
- Hippus is not a feature of opioid toxicity.
*Neuromuscular blocking agent poisoning*
- Neuromuscular blocking agents primarily affect the **skeletal muscles**, leading to **paralysis** but generally do not directly impact pupil size or reactivity.
- Pupils usually remain **mid-dilated and fixed** in severe paralysis, but not hippus.
*Belladonna poisoning*
- Belladonna (atropine) poisoning causes **mydriasis (dilated pupils)** due to its anticholinergic effect, blocking parasympathetic activity.
- The pupils are typically fixed and dilated, not exhibiting hippus.
Neuromuscular Blocking Agents Indian Medical PG Question 9: Which of the following is not a recognized use of alpha-2-agonists?
- A. Glaucoma
- B. Hypertension
- C. Sedation
- D. Benign Hyperplasia of prostate (Correct Answer)
Neuromuscular Blocking Agents Explanation: ***Correct Answer: Benign Hyperplasia of prostate***
- Alpha-2-agonists are **NOT** used to treat **benign prostatic hyperplasia (BPH)**; this condition is typically managed with **alpha-1-blockers** (e.g., tamsulosin, alfuzosin) or 5-alpha-reductase inhibitors.
- Alpha-1-blockers relax the smooth muscle in the prostate and bladder neck, improving urine flow, which involves a different receptor mechanism than alpha-2-agonists.
- Alpha-2-agonists would not provide therapeutic benefit for BPH.
*Incorrect: Glaucoma*
- Alpha-2-agonists (e.g., **brimonidine**, **apraclonidine**) **are** used to treat **glaucoma** by reducing aqueous humor production and increasing uveoscleral outflow.
- This action helps to **lower intraocular pressure**, a primary goal in glaucoma management.
*Incorrect: Hypertension*
- Central-acting alpha-2-agonists (e.g., **clonidine**, **methyldopa**) **are** used as **antihypertensive agents**.
- They reduce sympathetic outflow from the central nervous system, leading to decreased heart rate, vasodilation, and consequently, **lower blood pressure**.
*Incorrect: Sedation*
- Alpha-2-agonists like **dexmedetomidine** and **clonidine** **are** commonly used for **sedation** in critically ill patients, especially in intensive care units.
- They produce sedation, analgesia, and anxiolysis without causing significant respiratory depression, making them valuable in certain clinical settings.
Neuromuscular Blocking Agents Indian Medical PG Question 10: Which sympathomimetic drug is primarily known to increase heart rate?
- A. Isoprenaline (Correct Answer)
- B. Phenylephrine
- C. Noradrenaline
- D. Adrenaline
Neuromuscular Blocking Agents Explanation: ***Isoprenaline***
- **Isoprenaline** (isoproterenol) is a non-selective beta-adrenergic agonist, with a strong affinity for **β1 and β2 receptors** [1].
- Its activation of **β1 receptors** in the heart leads to a significant increase in **heart rate (positive chronotropy)** and contractility (positive inotropy) [1].
- It is the **most potent chronotropic agent** among sympathomimetics and is primarily known for increasing heart rate [2].
*Phenylephrine*
- **Phenylephrine** is a selective **α1 adrenergic agonist** that causes vasoconstriction [4].
- It increases blood pressure but typically causes **reflex bradycardia** (decreased heart rate) due to baroreceptor activation.
- Does NOT directly increase heart rate.
*Noradrenaline*
- **Noradrenaline** (norepinephrine) primarily acts on **α1 receptors** causing vasoconstriction, and to a lesser extent on **β1 receptors** [3].
- While it can stimulate β1 receptors, its predominant effect is to increase **mean arterial pressure** through vasoconstriction, often causing **reflex bradycardia** [3].
*Adrenaline*
- **Adrenaline** (epinephrine) acts on **α1, β1, and β2 receptors** [4]. While it does increase heart rate via **β1 receptor** stimulation, it also causes significant **vasoconstriction** (via α1) and **vasodilation** (via β2).
- Its cardiovascular effects are more complex and dose-dependent compared to isoprenaline's specific chronotropic action.
More Neuromuscular Blocking Agents Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
